Afatinib in Advanced NRG1-Rearranged Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04410653

Recruitment Status : Not yet recruiting

First Posted : June 1, 2020

Last Update Posted : April 13, 2021

See Contacts and Locations

Sponsor:

Collaborator:

German Consortium for Translational Cancer Research

Information provided by (Responsible Party):

German Cancer Research Center

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Not yet recruiting
Estimated Primary Completion Date :	December 1, 2023
Estimated Study Completion Date :	December 1, 2023

To Top